Business Context and Reporting Period
This Form 8-K is a current report filed by Shuttle Pharmaceuticals Holdings, Inc. on September 2, 2026. The filing addresses a corporate governance event regarding the scheduling of a Special Meeting of stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a procedural update regarding a stockholder meeting and does not contain financial performance data.
Material Changes
The primary material change reported is the postponement of the Special Meeting of stockholders:
- Original Date: September 3, 2026, at 11:00 a.m. Eastern Time.
- New Date: September 9, 2026, at 11:00 a.m. Eastern Time (Reconvened Special Meeting).
- New Voting Deadline: Proxies must be received by 11:59 p.m. Eastern Time on September 8, 2026.
Guidance, Outlook, and Management Commentary
Management stated the decision to postpone was made to:
- Allow additional time to solicit proxies from stockholders.
- Provide stockholders more time to consider proposals and vote to facilitate broader participation.
- Allow stockholders additional time to consider an amendment to the terms of Milestone Events described in a prior Form 8-K filed on September 1, 2026.
Valid proxies submitted prior to the original meeting date remain valid for the Reconvened Special Meeting unless properly changed or revoked.
Investor Verification Checklist
- Verify the new voting deadline of September 8, 2026, to ensure proxy votes are counted.
- Review the Definitive Proxy Statement on Schedule 14A (filed August 13, 2026) for details on the proposals to be voted on.
- Examine the Form 8-K filed on September 1, 2026, to understand the specific amendments to Milestone Event terms referenced in this filing.
- Confirm that existing proxy authorizations have not been revoked prior to the new meeting date.